CATHERINE ROBERTS: Open Payments
NPI 1447210778 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 68 payments from 9 companies in 2025. Trend: 2023 $4,379 · 2024 $4,474 · 2025 $1,426
Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 30 | $807 |
| GlaxoSmithKline, LLC. | 19 | $181 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| GENZYME CORPORATION | 4 | $70 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| ARRAY BIOPHARMA INC | 1 | $17 |
Products named: INSPIRE, TRELEGY ELLIPTA, DUPIXENT, OFEV, GLASSIA, NUCALA, Sunosi, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
